MYGN Myriad Genetics Inc

Myriad Genetics Inc is a molecular diagnostic company. It develops and markets novel predictive medicine, personalized medicine and prognostic medicine tests. It also provides physicians with information to solve unmet medical needs.

$32.62  -0.10 (-0.31%)
As of 09/16/2021 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/26/2001
Outstanding shares:  78,055,365
Average volume:  410,383
Market cap:   $2,553,971,543
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    62855J104
ISIN:        US62855J1043
Sedol:      2614153
Valuation   (See tab for details)
PE ratio:   -24.58
PB ratio:   2.81
PS ratio:   3.86
Return on equity:   -11.48%
Net income %:   -15.64%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy